Drug Prices
Patients and their providers rely on these prescription drugs for treating injury and managing illness. Yet the drug companies and their shareholders have been treating America’s patients and providers like a piggybank.
The Senate Finance Committee today held the second in a planned series of bipartisan hearings on high prescription drug prices, which featured executives from drug companies AbbVie, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Merck, Pfizer and Sanofi.
The Food and Drug Administration Friday released draft guidance on how drug developers can apply for the agency’s Competitive Generic Therapies designation.
Committee Chairman Richard Neal, D-Mass., and Ranking Member Kevin Brady, R-Texas, said they are committed to working on bipartisan reforms to lower drug prices.
The AHA, Federation of ºÚÁÏÕýÄÜÁ¿s, and American Society of Health-System Pharmacists today convened a panel of experts on Capitol Hill to discuss how continued rising drug prices, as well as shortages for many critical medications, are disrupting patient care and forcing hospitals to delay…
Nearly 50 health care and consumer groups, including the AHA, voiced their support for the Creating and Restoring Equal Access to Equivalent Samples Act as it was reintroduced yesterday in the new Congress.
The Senate Health, Education, Labor & Pensions Committee today held a hearing to examine how primary care affects health care costs and outcomes.
The Department of Health and Human Services’ Office of Inspector General yesterday proposed excluding from safe harbor protection under the Anti-Kickback Statute rebates paid by prescription drug makers to pharmacy benefit managers, Medicare Part D plans and Medicaid managed care organizations.
The Senate Finance Committee today held the first in a planned series of bipartisan hearings on high prescription drug prices and potential policy and oversight solutions to lower costs for patients.
Also in this weekly roundup of health care related news: Cleveland Clinic leader discusses health care trends, and how one health system uses real-time data to make clinical decisions.